Key result
Rapid coagglutination tests demonstrated 100% sensitivity for MSS strains and 99-100% for MRS strains, but false-positive rates of 2-10% make their clinical usefulness problematic.
Why the study?
Do rapid coagglutination tests accurately differentiate Staphylococcus aureus from other staphylococcal species compared to standard coagulase and nuclease tests?
Cross-Sectional (n=300)
Do rapid coagglutination tests accurately differentiate Staphylococcus aureus from other staphylococcal species compared to standard coagulase and nuclease tests?
The high false-positive rates of rapid coagglutination tests make their clinical usefulness problematic, supporting the continued use of tube coagulase and thermostable nuclease tests for differentiating S. aureus.
Answers are grounded in this paper and cite their sources.
High false-positive rates advise against routine use of rapid coagglutination tests; leaves open their optimization versus standard methods in prospective lab validation.
Three commercial coagglutination tests--Sero-STAT, Accu-Staph, and Staphyloslide--were performed in parallel with slide coagulase, tube coagulase, and thermostable nuclease tests on 100 methicillin-susceptible Staphylococcus aureus (MSS) strains, 100 methicillin-resistant S. aureus (MRS) strains, and 100 non-S. aureus staphylococcal strains (NSA). All three coagglutination tests showed sensitivities of 100% for MSS strains. For MRS strains, sensitivities were, respectively, 99%, 100%, and 99%. False-positive reactions were, respectively, 10%, 2%, and 2%. A marked difference in slide coagulase test sensitivity was found for MSS strains (79%) and MRS strains (14%). These findings suggest that the coagglutination tests may be less sensitive for detecting MRS strains than for detecting MSS strains and that these properties may be related to clumping factor reactivity. The high false-positive rate for Sero-STAT and even the 2% false-positive rate for Accu-Staph and Staphyloslide make clinical usefulness at this time somewhat problematic and debatable. In view of these findings, the authors prefer to retain the tube coagulase test and thermostable nuclease test for differentiation of S. aureus from non-S. aureus strains in their laboratory.
No takes yet. Share an insight, caveat, or question.
Woolfrey et al. (1984) conducted a cross-sectional in Staphylococcus aureus identification (n=300). Rapid coagglutination tests (Sero-STAT, Accu-Staph, and Staphyloslide) vs. Slide coagulase, tube coagulase, and thermostable nuclease tests was evaluated on Sensitivity and false-positive rates for differentiating S. aureus from other staphylococci. Rapid coagglutination tests demonstrated 100% sensitivity for MSS strains and 99-100% for MRS strains, but false-positive rates of 2-10% make their clinical usefulness problematic.
Synapse has enriched 10 related papers. Consider them for comparative context: